Cite

HARVARD Citation

    Hong, N. et al. (n.d.). The preclinical characterization of the N-terminal domain androgen receptor inhibitor, EPI-7386, for the treatment of prostate cancer. European journal of cancer. pp. S51-. [Online]. 
  
Back to record